Integra LifeSciences Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Lake Street Capital Markets Upgrades Integra LifeSciences (IART) to Buy
October 28, 2016 8:26 AM EDTLake Street Capital Markets upgraded Integra LifeSciences (NASDAQ: IART) from Hold to Buy with a price target of $92.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $77.07 yesterday.
... MoreIntegra LifeSciences (IART) Tops Q3 EPS by 4c
October 27, 2016 4:08 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $250.3 million versus the consensus estimate of $249.3 million.
GUIDANCE:
Integra LifeSciences sees FY2016 EPS of $3.47-$3.53, versus the consensus of... More
